Vd9.0

Vitamin D3

Vitamin D3 (Cholecalciferol)

The 'sunshine vitamin' essential for immune function, mood, bone health, and regulating over 1,000 genes in the body.

immunitymentalimmunemoodboneshormones
Last reviewed: January 1, 2025
9.0/10
40+ studies
Evidence
high
Safety
2000-4000 IU daily
Dose
8-12 weeks
Time to Effect
D3 (cholecalciferol) softgel or liquid
Best Form

Vitamin D3 is a fat-soluble vitamin that functions as a hormone in the body. Deficiency is extremely common, especially in northern latitudes, and is linked to poor immune function, depression, muscle weakness, and bone loss. Optimal blood levels are 40-60 ng/mL.

Mechanisms of Action

🛡️
Immune Regulation

Modulates both innate and adaptive immune responses

🧬
Gene Expression

Regulates over 1,000 genes throughout the body

🦴
Calcium Metabolism

Essential for calcium absorption and bone health

Recommended Dose

2000-4000 IU daily

1000IU4000IU

Loading: If severely deficient (<20 ng/mL): 50,000 IU weekly for 8 weeks under medical supervision

Optimal Timing

  • Morning with breakfast

Take with food

Best Form

D3 (cholecalciferol) softgel or liquid

Alternatives: D3 tablets, D3 drops

D3 is more effective than D2 (ergocalciferol). Oil-based softgels or liquid drops absorb best. Test blood levels after 2-3 months.

Duration

Minimum: 8 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Take with a meal containing fat for best absorption. Morning is preferred as evening doses may interfere with sleep in some people.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🛡️
Stronger Immunity

Reduced frequency and severity of infections

4-8 weeks
75% of users notice thispositive
😊
Improved Mood

Better mood and reduced seasonal depression symptoms

4-8 weeks
65% of users notice thispositive
⚡
More Energy

Reduced fatigue, especially if previously deficient

2-4 weeks
60% of users notice thispositive
💪
Better Muscle Function

Improved strength and reduced muscle pain

4-8 weeks
55% of users notice thispositive
High SafetyMax safe dose: 4000 IU/day is the official upper limit; up to 10,000 IU appears safe but monitor blood levels
🟢
Pregnant/nursing

Generally recommended; 1000-4000 IU is considered safe

🟡
Elderly

Often need higher doses due to reduced skin synthesis

🟡
Dark skin

May need higher doses; melanin reduces vitamin D synthesis

Who Should NOT Take This

  • Hypercalcemia
  • Kidney disease (consult doctor)
  • Sarcoidosis or other granulomatous diseases

Drug Interactions

Thiazide diureticsmoderate

May increase calcium levels

Steroidsmild

Steroids may reduce vitamin D absorption

Statinsmild

Both metabolized by liver; monitor if using high doses — both affect lipid metabolism; may increase risk of myopathy through additive effects on muscle tissue

Possible Side Effects

Hypercalcemia (at very high doses)uncommon

Tip: Don't exceed 10,000 IU daily without monitoring

GI upsetrare

Tip: Take with food

Warnings

  • Test blood levels before and during supplementation
  • Target 40-60 ng/mL for optimal levels
  • Toxicity is rare but possible with mega-doses
  • Doses above 4000 IU should only be taken under medical supervision

Top studies from 40+ peer-reviewed papers

meta-analysisn=5205
DOI

Tobias DK et al. • Nature communications (2025)

“This meta-analysis examined the effects of Vitamin D3.”
Key Findings:
  • Mean body mass index (BMI) was 27.5 kg/m2 (SD = 5.3), with 51% female and 17% Black race/ethnicity.
  • T2D incidence (cases/1000py) at median follow-up of 5.3 y was 3.98 for vitamin D and 4.37 for placebo (hazard ratio [HR] = 0.91; 95% confidence interval [CI] = 0.76, 1.09).
  • In conclusion, Vitamin D supplementation did not reduce T2D in older US adults, but a modest reduction was observed when meta-analyzed with prior trials.
  • Trial Registration: ClinicalTrials.gov #NCT01633177.
meta-analysisn=687
DOI

Lin KC et al. • Nutrients (2024)

“In conclusion, although substantial heterogeneity persists, vitamin D supplementation decreased pain intensity in patients with dysmenorrhea, especially in those with primary dysmenorrhoea.”
Key Findings:
  • TSA revealed that the current RCTs provide sufficient information.
  • In subgroup analyses, vitamin D supplement reduced primary dysmenorrhoea pain but not secondary dysmenorrhoea pain.
  • In conclusion, although substantial heterogeneity persists, vitamin D supplementation decreased pain intensity in patients with dysmenorrhea, especially in those with primary dysmenorrhoea.
meta-analysisn=3960
DOI

Ma K et al. • Nutrients (2021)

“Vitamin D supplementation during pregnancy or infancy may be associated with reduced adiposity in childhood.”
Key Findings:
  • Vitamin D supplementation during pregnancy was associated with higher triceps skinfold thickness (mm) (MD 0.33, 95% CI, 0.12, 0.54; I2 = 34%) in neonates.
  • Vitamin D supplementation during pregnancy or infancy may be associated with reduced adiposity in childhood.
  • Further large clinical trials of the effects of vitamin D supplementation on childhood body composition are warranted.
meta-analysisn=11321
DOI

Martineau AR et al. • BMJ (2017)

“Vitamin D supplementation reduced the risk of acute respiratory tract infection, with stronger effects in those with profound deficiency.”
Key Findings:
  • 12% reduction in respiratory infections overall
  • 70% reduction in severely deficient individuals
  • Daily/weekly dosing more effective than large boluses
meta-analysisn=9294
DOI

Bischoff-Ferrari HA et al. • JAMA (2005)

“Oral vitamin D supplementation between 700 to 800 IU/d appears to reduce the risk of hip and any nonvertebral fractures in ambulatory or institutionalized elderly persons.”
Key Findings:
  • Oral vitamin D supplementation between 700 to 800 IU/d appears to reduce the risk of hip and any nonvertebral fractures in ambulatory or institutionalized elderly persons.
  • An oral vitamin D dose of 400 IU/d is not sufficient for fracture prevention.
  • Further research warranted to confirm findings
40
Total Studies
9.2/10
Avg Quality
13-31,424
Sample Size Range
2005-2025
Research Span

Study Type Distribution

Meta-Analysis
26
RCT
12
Systematic Review
2

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.